The National Home Infusion Association (NHIA) is pleased to announce the 2023 Fellow Program (FNHIA) cohort, made up of highly accomplished home and alternate site infusion professionals.
NHIA President & CEO Connie Sullivan responds to recent alarmist news stories based on flawed research about CLABSI surveillance in home infusion.
“Misleading stories about the risks of home infusion have real consequences and may result in fewer patients eventually having access to these essential services.”
NHIA is disappointed by the characterization of a recent study regarding infection control in home infusion, which the association asserts is not at all reflective of home infusion therapy standards and practices.
Danell Haines, PhD, Research Consultant; Ryan Garst, PharmD, MBA, IgCP, BCSCP, NHIA
Determine the home infusion pharmacist’s time commitment to tasks involved with onboarding a home infusion patient.
Sofia Shrestha, PharmD, CSP, Fairview Home Infusion; Dana Simonson, PharmD, BCPS, Fairview Pharmacy Services; Alicia Zagel, PhD, MPH, Fairview Pharmacy Services
Measure the incidence and severity of infusion-related reactions in patients receiving ocrelizumab administered in both hospital-based and outpatient sites of care.
Danell Haines, PhD Research Consultant; Ryan Garst, PharmD, MBA, IgCP, BCSCP, NHIA
NHIF retrospectively collected and analyzed data from the REGEN-COV patient charts. Data analysis showed that home infused REGENCOV achieved comparable outcomes to other sites of care and provided improved access to treatment.
On December 2, 2022, NHIA sent a follow-up letter to Defense Health Agency, including a copy to Express Scripts (ESI), sharing recent updates on efforts by ESI to narrow the TRICARE pharmacy network and urging the DOD to reinstate all home infusion providers to the ESI network to prevent disruptions in home infusion access for TRICARE beneficiaries.
NHIA’s Clinical Program Manager Michelle Simpson, PharmD, BCSCP, MWC presented research conducted by the National Home Infusion Foundation (NHIF) at ID Week, the meeting of the Infectious Diseases Society of America (IDSA) held October 19-23 in Washington, D.C.
A diverse group of 30 patient and stakeholder groups are calling on Congress to address Medicare beneficiary access to home infusion services. In a letter to lawmakers, which brings together stakeholders from across the care continuum, the groups urge congressional leaders to advance the Preserving Patient Access to Home Infusion Act (S. 2652/H.R. 5067) and increase access to home infusion therapy for Medicare beneficiaries.
Registration is now open for the National Home Infusion Association’s 2023 Annual Conference (NHIA 2023), to be held March 25-29, 2023, at the Gaylord National Resort & Convention Center in Washington, D.C.
NHIA member pharmacies began reporting that TRICARE patients had received letters from Express Scripts stating the local home infusion pharmacy they currently use will not be in network as of October 24, 2022. NHIA sent a letter to Defense Health Agency and Express Scripts requesting the repeal of any network pharmacy cancellations.
The National Home Infusion Association (NHIA) was honored as a “COVID Hero of New York” by NewYorkBIO, a group that brings together nearly 300 of the state’s bioscience companies, universities, research institutions, and others dedicated to advancing life science research and commercialization.
NHIA submitted comments pointing out the advantages of home-based administration of subcutaneous Ig (SCIG) for chronic inflammatory demyelinating polyneuropathy (CIPD).
Support NHIF and Infuse Wellness this October into your life and others. There are many ways to participate—get together with your colleagues and form a team to compete against the NHIA staff and other members.
NHIA committees bring together thought leaders and innovators to complement and support staff efforts to promote and achieve the association’s mission.
NHIA submitted comments on a CMS proposed rule (CMS-1770-P) that would affect Medicare payments and coverage of COVID-19 vaccines and monoclonal antibodies (mAbs) and coding and billing requirements related to the use of single dose containers and drug waste.
Dozens of health systems, hospitals, and group purchasing organizations are calling on Congress to address Medicare beneficiary access to home infusion services and pass legislation that would increase access to home-based care, urging congressional leaders to advance the Preserving Patient Access to Home Infusion Act (S. 2652/H.R. 5067) to encourage access to home infusion therapy for Medicare beneficiaries.
The National Home Infusion Association (NHIA) is pleased to announce the 2023 Fellow Program (FNHIA) cohort, made up of highly accomplished home and alternate site infusion professionals.
NHIA President & CEO Connie Sullivan responds to recent alarmist news stories based on flawed research about CLABSI surveillance in home infusion.
“Misleading stories about the risks of home infusion have real consequences and may result in fewer patients eventually having access to these essential services.”
NHIA is disappointed by the characterization of a recent study regarding infection control in home infusion, which the association asserts is not at all reflective of home infusion therapy standards and practices.
Danell Haines, PhD, Research Consultant; Ryan Garst, PharmD, MBA, IgCP, BCSCP, NHIA
Determine the home infusion pharmacist’s time commitment to tasks involved with onboarding a home infusion patient.
Sofia Shrestha, PharmD, CSP, Fairview Home Infusion; Dana Simonson, PharmD, BCPS, Fairview Pharmacy Services; Alicia Zagel, PhD, MPH, Fairview Pharmacy Services
Measure the incidence and severity of infusion-related reactions in patients receiving ocrelizumab administered in both hospital-based and outpatient sites of care.
Danell Haines, PhD Research Consultant; Ryan Garst, PharmD, MBA, IgCP, BCSCP, NHIA
NHIF retrospectively collected and analyzed data from the REGEN-COV patient charts. Data analysis showed that home infused REGENCOV achieved comparable outcomes to other sites of care and provided improved access to treatment.
On December 2, 2022, NHIA sent a follow-up letter to Defense Health Agency, including a copy to Express Scripts (ESI), sharing recent updates on efforts by ESI to narrow the TRICARE pharmacy network and urging the DOD to reinstate all home infusion providers to the ESI network to prevent disruptions in home infusion access for TRICARE beneficiaries.
NHIA’s Clinical Program Manager Michelle Simpson, PharmD, BCSCP, MWC presented research conducted by the National Home Infusion Foundation (NHIF) at ID Week, the meeting of the Infectious Diseases Society of America (IDSA) held October 19-23 in Washington, D.C.
A diverse group of 30 patient and stakeholder groups are calling on Congress to address Medicare beneficiary access to home infusion services. In a letter to lawmakers, which brings together stakeholders from across the care continuum, the groups urge congressional leaders to advance the Preserving Patient Access to Home Infusion Act (S. 2652/H.R. 5067) and increase access to home infusion therapy for Medicare beneficiaries.
Registration is now open for the National Home Infusion Association’s 2023 Annual Conference (NHIA 2023), to be held March 25-29, 2023, at the Gaylord National Resort & Convention Center in Washington, D.C.
NHIA member pharmacies began reporting that TRICARE patients had received letters from Express Scripts stating the local home infusion pharmacy they currently use will not be in network as of October 24, 2022. NHIA sent a letter to Defense Health Agency and Express Scripts requesting the repeal of any network pharmacy cancellations.
The National Home Infusion Association (NHIA) was honored as a “COVID Hero of New York” by NewYorkBIO, a group that brings together nearly 300 of the state’s bioscience companies, universities, research institutions, and others dedicated to advancing life science research and commercialization.
NHIA submitted comments pointing out the advantages of home-based administration of subcutaneous Ig (SCIG) for chronic inflammatory demyelinating polyneuropathy (CIPD).
Support NHIF and Infuse Wellness this October into your life and others. There are many ways to participate—get together with your colleagues and form a team to compete against the NHIA staff and other members.
NHIA committees bring together thought leaders and innovators to complement and support staff efforts to promote and achieve the association’s mission.
NHIA submitted comments on a CMS proposed rule (CMS-1770-P) that would affect Medicare payments and coverage of COVID-19 vaccines and monoclonal antibodies (mAbs) and coding and billing requirements related to the use of single dose containers and drug waste.
Dozens of health systems, hospitals, and group purchasing organizations are calling on Congress to address Medicare beneficiary access to home infusion services and pass legislation that would increase access to home-based care, urging congressional leaders to advance the Preserving Patient Access to Home Infusion Act (S. 2652/H.R. 5067) to encourage access to home infusion therapy for Medicare beneficiaries.
